| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | Sprang Todd A. Director | Purchase | +450 | +28.75%2,015 | $138.96 | $62,532 | View SEC filing | |
| 2026-04-23 | Stayer-Suprick Michael S Director | Purchase | +225 | +5.15%4,597 | $140.04 | $31,509 | View SEC filing | |
| 2026-02-12 | Eldred Steven M Director | Sale | -16,000 | -11.29%125,680 | $148.49 | $2,375,760 | View SEC filing | |
| 2026-01-30 | Sprang Todd A. Director | Purchase | +150 | +14.88%1,158 | $141.06 | $21,159 | View SEC filing | |
| 2025-08-20 | Stayer-Suprick Michael S Director | Purchase | +410 | +11.53%3,965 | $122.67 | $50,295 | View SEC filing | |
| 2025-03-19 | MCCONEGHY DANIEL C Director | Purchase | +380 | +23.46%2,000 | $105.72 | $40,174 | View SEC filing | |
| 2025-02-19 | Stayer-Suprick Michael S Director | Purchase | +1,000 | +49.14%3,035 | $102.07 | $102,070 | View SEC filing | |
| 2024-12-03 | Johnson Stephen E Director | Sale | -2,400 | -8.23%26,763 | $106.28 | $255,072 | View SEC filing | |
| 2024-03-18 | Bourbulas Mary Kay Director | Purchase | +600 | +9.37%7,003 | $82.88 | $49,725 | View SEC filing | |
| 2024-02-08 | Maples Phillip R Director | Purchase | +650 | +48.76%1,983 | $81.72 | $53,118 | View SEC filing | |
| 2023-10-31 | LeMahieu Kevin M. Chief Financial Officer | Purchase | +582 | +2.92%20,544.5 | $70.00 | $40,740 | View SEC filing | |
| 2023-02-22 | Molepske Michael B. Chairman and CEO | Sale | -10,000 | -19.08%42,401 | $80.25 | $802,500 | View SEC filing | |
| 2023-02-21 | Molepske Michael B. Chairman and CEO | Sale | -10,000 | -18.54%43,934 | $80.25 | $802,500 | View SEC filing | |
| 2022-05-23 | Maples Phillip R Director | Purchase | +700 | +108.36%1,346 | $70.00 | $49,000 | View SEC filing | |
| 2021-08-06 | Molepske Michael B. CEO and President | Purchase | +1,000 | +2.33%43,959 | $69.50 | $69,500 | View SEC filing | |
| 2021-02-08 | Bourbulas Mary Kay Director | Purchase | +600 | +19.08%3,745 | $68.89 | $41,336 | View SEC filing | |
| 2021-01-28 | Bourbulas Mary Kay Director | Purchase | +1,000 | +46.62%3,145 | $69.99 | $69,990 | View SEC filing | |
| 2020-11-27 | Bourbulas Mary Kay Director | Purchase | +1,200 | +126.98%2,145 | $67.85 | $81,420 | View SEC filing | |
| 2020-11-24 | Molepske Michael B. Chief Executive Officer | Sale | -5,000 | -10.43%42,959 | $65.00 | $325,000 | View SEC filing | |
| 2020-11-05 | Holmes Robert W. Director | Sale | +20,578 | N/A0 | $62.33 | $1,282,627 | View SEC filing | |
| 2020-05-20 | Bourbulas Mary Kay Director | Purchase | +100 | +11.83%945 | $55.00 | $5,500 | View SEC filing | |
| 2020-05-19 | Bourbulas Mary Kay Director | Purchase | +100 | +13.42%845 | $56.00 | $5,600 | View SEC filing | |
| 2020-05-15 | Bourbulas Mary Kay Director | Purchase | +171 | +29.79%745 | $49.50 | $8,465 | View SEC filing | |
| 2020-05-13 | LeMahieu Kevin M. Chief Financial Officer | Purchase | +1,030 | +6.90%15,959 | $50.30 | $51,809 | View SEC filing | |
| 2020-03-24 | Molepske Michael B. Chief Executive Officer | Purchase | +2,192 | +100.00%2,192 | $60.37 | $132,331 | View SEC filing |
1-25 of 41
